Thrombocytopenia—A Rare But Potentially Serious Side Effect of Initial Daily and Interrupted Use of Rifampicin-Reference-Cited by-同舟云学术

Thrombocytopenia—A Rare But Potentially Serious Side Effect of Initial Daily and Interrupted Use of Rifampicin

Published:1989-07 Issue:1 Volume:96 Page:202-203
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Lee Cheng-Huei,Lee Ching-Jyh

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference12 articles.

1. Adverse effect of antimycobacterial drugs.;Girling;Drugs,1982

2. Adverse reactions to rifampicin in antituberculosis.;Girling;J Antimicrob Chemother,1977

3. Rifampicin induced immune thrombocytopenia.;Blajchman;Br Med J,1970

4. Adverse reactions to daily and intermittent regimens for pulmonary tuberculosis in Hong Kong.;Aquinas;Br Med J,1972

5. Singapore Tuberculosis Service/British Medical Research Council. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore—The results up to 30 months. Am Rev Respir Dis 1977; 116:807-20

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of severe thrombocytopenia after the first exposure to rifampicin;Respiratory Medicine Case Reports;2023

2. Isoniazid-induced Immune Thrombocytopenia;Internal Medicine;2021-11-15

3. Rifampicin-Induced Thrombocytopenia: A Case Report and Short Review of the Literature;European Medical Journal;2021-04-19

4. Rifampin Pharmacokinetics and Safety in Preterm and Term Infants;Antimicrobial Agents and Chemotherapy;2019-06

5. Monitoring Treatment of Childhood Tuberculosis and the Role of Therapeutic Drug Monitoring;The Indian Journal of Pediatrics;2019-02-28